Ignite Creation Date:
2025-12-26 @ 4:00 PM
Ignite Modification Date:
2026-02-05 @ 9:06 PM
Study NCT ID:
NCT05320406
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-06
First Post:
2022-03-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
RElugolix VErsus LeUprolide Cardiac Trial
Sponsor:
Emory University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Biochemically Recurrent Prostate Carcinoma | View |
| None | Localized Prostate Carcinoma | View |
| None | Stage I Prostate Cancer AJCC v8 | View |
| None | Stage II Prostate Cancer AJCC v8 | View |
| None | Stage IIA Prostate Cancer AJCC v8 | View |
| None | Stage IIB Prostate Cancer AJCC v8 | View |
| None | Stage IIC Prostate Cancer AJCC v8 | View |
| None | Stage III Prostate Cancer AJCC v8 | View |
| None | Stage IIIA Prostate Cancer AJCC v8 | View |
| None | Stage IIIB Prostate Cancer AJCC v8 | View |
| None | Stage IIIC Prostate Cancer AJCC v8 | View |
Keywords: